跳至主要内容
临床试验/IRCT2013120715695N1
IRCT2013120715695N1已完成3 期

The effect of Pentoxifylline on C reactive protein level and dialysis adequacy in end stage renal disease patients under hemodialysis

Arak University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 no limit(—)
性别
All

入选标准

  • acceptance of written consent; End Stage Renal Disease; more than 15year; BMI between 15 - 35
  • Exclusion criteria: pentoxifylline use before study; no acceptance of written consent; abnormal LFT; hyper sensitivity reaction to pentoxifylline; active infection; recent malignancy; depression;recent ICH; recent retinal hemorrhage; dialysis period under 3 months

排除标准

  • 未提供

研究者

相似试验